Q/C Technologies, Inc. Common Stock is a in vitro & in vivo diagnostic substances company trading on NASDAQ, led by CEO Joshua N. Silverman, with a market cap of $28.0M.
Common questions about Q/C Technologies, Inc. Common Stock
Q/C Technologies, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 14, 2026.
We use cookies for analytics. See our Privacy and Cookie Policy.